IFNG and central nervous system cancer: The results obtained show that about 2% of patients with GB and 18% of patients with non-GB gliomas were still alive 1000 days after surgery or therapy; these patients had a combination of cytokines (IL-4/IL-5/IL-6, IFN-γ/TNF-α/IL-17A).